ETOLOL CT 50/12.5

Etolol CT Tablet ER is indicated for the management of hypertension, a condition characterized by elevated blood pressure levels. This medication is effective in instances where monotherapy does not adequately control blood pressure. Additionally, it serves to mitigate the risk of subsequent cardiovascular events, including myocardial infarction and cerebrovascular accidents (strokes). Initiating treatment with Etolol CT can enhance survival rates in individuals who have experienced a heart attack. The tablet is typically administered in the morning, with or without food, to minimize nocturnal urinary frequency. It is essential to adhere to your healthcare provider’s recommendations regarding the duration of treatment. Discontinuation of the medication without medical guidance can lead to exacerbation of hypertension, which often presents asymptomatically. To further support blood pressure management, maintaining an active lifestyle through regular exercise, achieving a healthy weight, and adhering to a balanced diet are strongly advised. Patients are encouraged to stay adequately hydrated to alleviate potential side effects such as muscle weakness, dry mouth, and excessive thirst. The occurrence of dizziness or headache may indicate reduced blood pressure but is generally transient. It is advisable to inform your healthcare professional of any existing renal or hepatic conditions prior to starting treatment, as well as any concurrent medications, particularly those targeting hypertension or cardiac issues. Regular monitoring of blood pressure, renal function, glycemic levels, and electrolyte concentrations, including potassium and magnesium, is recommended to ensure therapeutic efficacy.